Publication | Open Access

A novel series of tacrine–selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease

Neurodegenerative DiseasesMedicinal ChemistryAlzheimer's DiseaseNovel SeriesMedicineNeuropharmacologyNeuroprotectionNeurologyNeurosciencePharmacologyTacrine–selegiline HybridsPharmaceutical ChemistryDrug Discovery